後発医薬品の世界市場予測2018-2023

【英語タイトル】Global Branded Generics Market Growth 2018-2023

LP Informationが出版した調査資料(LPIN8N0866)・商品コード:LPIN8N0866
・発行会社(調査会社):LP Information
・発行日:2018年10月22日
・ページ数:131
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥395,280見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥592,920見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥790,560見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「後発医薬品の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、経口、非経口、局所的、その他など、用途別には、腫瘍学、心血管疾患、糖尿病、神経学、胃腸疾患などに区分してまとめた調査レポートです。後発医薬品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向、販売チャネルなどの情報が含まれています。
・後発医薬品の世界市場概要(サマリー)
・後発医薬品の企業別販売量・売上
・後発医薬品の企業別市場シェア
・後発医薬品の世界市場規模:種類別(経口、非経口、局所的、その他)
・後発医薬品の世界市場規模:用途別(腫瘍学、心血管疾患、糖尿病、神経学、胃腸疾患)
・後発医薬品の米州市場規模(アメリカ、カナダ、メキシコなど)
・後発医薬品のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・後発医薬品の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・後発医薬品の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・後発医薬品市場の成長要因・課題・動向
・後発医薬品の販売チャネル、流通業者、顧客
・後発医薬品の世界市場予測
・後発医薬品の米州市場予測(アメリカ、カナダ、メキシコなど)
・後発医薬品のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・後発医薬品の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・後発医薬品の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・後発医薬品の世界市場予測:種類別(経口、非経口、局所的、その他)
・後発医薬品の世界市場予測:用途別(腫瘍学、心血管疾患、糖尿病、神経学、胃腸疾患)
・主要企業分析
【レポートの概要】

A branded generic is a drug that is bioequivalent to the original product, but is now marketed under another company’s brand name. Branded generics are an attractive business for Valeant’s Emerging Markets operations as they enjoy low research and development costs and sustainable sales.
North America accounts for the largest market size of branded generics in 2017 and is projected to lead the market over the forecast period of 2018 to 2025.
Over the next five years, LPI(LP Information) projects that Branded Generics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Branded Generics market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Branded Generics market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Oral
Parenteral
Topical
Other
Segmentation by application:
Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Valeant Pharmaceuticals International

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Branded Generics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Branded Generics market by identifying its various subsegments.
Focuses on the key global Branded Generics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Branded Generics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Branded Generics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

2018-2023 Global Branded Generics Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Branded Generics Consumption 2013-2023
2.1.2 Branded Generics Consumption CAGR by Region
2.2 Branded Generics Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.2.3 Topical
2.2.4 Other
2.3 Branded Generics Consumption by Type
2.3.1 Global Branded Generics Consumption Market Share by Type (2013-2018)
2.3.2 Global Branded Generics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Branded Generics Sale Price by Type (2013-2018)
2.4 Branded Generics Segment by Application
2.4.1 Oncology
2.4.2 Cardiovascular Diseases
2.4.3 Diabetes
2.4.4 Neurology
2.4.5 Gastrointestinal Diseases
2.5 Branded Generics Consumption by Application
2.5.1 Global Branded Generics Consumption Market Share by Application (2013-2018)
2.5.2 Global Branded Generics Value and Market Share by Application (2013-2018)
2.5.3 Global Branded Generics Sale Price by Application (2013-2018)

3 Global Branded Generics by Players
3.1 Global Branded Generics Sales Market Share by Players
3.1.1 Global Branded Generics Sales by Players (2016-2018)
3.1.2 Global Branded Generics Sales Market Share by Players (2016-2018)
3.2 Global Branded Generics Revenue Market Share by Players
3.2.1 Global Branded Generics Revenue by Players (2016-2018)
3.2.2 Global Branded Generics Revenue Market Share by Players (2016-2018)
3.3 Global Branded Generics Sale Price by Players
3.4 Global Branded Generics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Branded Generics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Branded Generics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Branded Generics by Regions
4.1 Branded Generics by Regions
4.1.1 Global Branded Generics Consumption by Regions
4.1.2 Global Branded Generics Value by Regions
4.2 Americas Branded Generics Consumption Growth
4.3 APAC Branded Generics Consumption Growth
4.4 Europe Branded Generics Consumption Growth
4.5 Middle East & Africa Branded Generics Consumption Growth

5 Americas
5.1 Americas Branded Generics Consumption by Countries
5.1.1 Americas Branded Generics Consumption by Countries (2013-2018)
5.1.2 Americas Branded Generics Value by Countries (2013-2018)
5.2 Americas Branded Generics Consumption by Type
5.3 Americas Branded Generics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Branded Generics Consumption by Countries
6.1.1 APAC Branded Generics Consumption by Countries (2013-2018)
6.1.2 APAC Branded Generics Value by Countries (2013-2018)
6.2 APAC Branded Generics Consumption by Type
6.3 APAC Branded Generics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Branded Generics by Countries
7.1.1 Europe Branded Generics Consumption by Countries (2013-2018)
7.1.2 Europe Branded Generics Value by Countries (2013-2018)
7.2 Europe Branded Generics Consumption by Type
7.3 Europe Branded Generics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Branded Generics by Countries
8.1.1 Middle East & Africa Branded Generics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Branded Generics Value by Countries (2013-2018)
8.2 Middle East & Africa Branded Generics Consumption by Type
8.3 Middle East & Africa Branded Generics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Branded Generics Distributors
10.3 Branded Generics Customer

11 Global Branded Generics Market Forecast
11.1 Global Branded Generics Consumption Forecast (2018-2023)
11.2 Global Branded Generics Forecast by Regions
11.2.1 Global Branded Generics Forecast by Regions (2018-2023)
11.2.2 Global Branded Generics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Branded Generics Forecast by Type
11.8 Global Branded Generics Forecast by Application

12 Key Players Analysis
12.1 Mylan NV
12.1.1 Company Details
12.1.2 Branded Generics Product Offered
12.1.3 Mylan NV Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Mylan NV News
12.2 Novartis AG
12.2.1 Company Details
12.2.2 Branded Generics Product Offered
12.2.3 Novartis AG Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Novartis AG News
12.3 Eva Pharmaceutical Industries
12.3.1 Company Details
12.3.2 Branded Generics Product Offered
12.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Eva Pharmaceutical Industries News
12.4 Pfizer
12.4.1 Company Details
12.4.2 Branded Generics Product Offered
12.4.3 Pfizer Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Pfizer News
12.5 Sun Pharmaceutical Industries
12.5.1 Company Details
12.5.2 Branded Generics Product Offered
12.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Sun Pharmaceutical Industries News
12.6 Aspen Pharmacare Holding
12.6.1 Company Details
12.6.2 Branded Generics Product Offered
12.6.3 Aspen Pharmacare Holding Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Aspen Pharmacare Holding News
12.7 Abbott Laboratories
12.7.1 Company Details
12.7.2 Branded Generics Product Offered
12.7.3 Abbott Laboratories Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Abbott Laboratories News
12.8 Valeant Pharmaceuticals International
12.8.1 Company Details
12.8.2 Branded Generics Product Offered
12.8.3 Valeant Pharmaceuticals International Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Valeant Pharmaceuticals International News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Branded Generics
Table Product Specifications of Branded Generics
Figure Branded Generics Report Years Considered
Figure Market Research Methodology
Figure Global Branded Generics Consumption Growth Rate 2013-2023 (K MT)
Figure Global Branded Generics Value Growth Rate 2013-2023 ($ Millions)
Table Branded Generics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Oral
Table Major Players of Oral
Figure Product Picture of Parenteral
Table Major Players of Parenteral
Figure Product Picture of Topical
Table Major Players of Topical
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Branded Generics Consumption Market Share by Type (2013-2018)
Figure Global Branded Generics Consumption Market Share by Type (2013-2018)
Table Global Branded Generics Revenue by Type (2013-2018) ($ million)
Table Global Branded Generics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Branded Generics Value Market Share by Type (2013-2018)
Table Global Branded Generics Sale Price by Type (2013-2018)
Figure Branded Generics Consumed in Oncology
Figure Global Branded Generics Market: Oncology (2013-2018) (K MT)
Figure Global Branded Generics Market: Oncology (2013-2018) ($ Millions)
Figure Global Oncology YoY Growth ($ Millions)
Figure Branded Generics Consumed in Cardiovascular Diseases
Figure Global Branded Generics Market: Cardiovascular Diseases (2013-2018) (K MT)
Figure Global Branded Generics Market: Cardiovascular Diseases (2013-2018) ($ Millions)
Figure Global Cardiovascular Diseases YoY Growth ($ Millions)
Figure Branded Generics Consumed in Diabetes
Figure Global Branded Generics Market: Diabetes (2013-2018) (K MT)
Figure Global Branded Generics Market: Diabetes (2013-2018) ($ Millions)
Figure Global Diabetes YoY Growth ($ Millions)
Figure Branded Generics Consumed in Neurology
Figure Global Branded Generics Market: Neurology (2013-2018) (K MT)
Figure Global Branded Generics Market: Neurology (2013-2018) ($ Millions)
Figure Global Neurology YoY Growth ($ Millions)
Figure Branded Generics Consumed in Gastrointestinal Diseases
Figure Global Branded Generics Market: Gastrointestinal Diseases (2013-2018) (K MT)
Figure Global Branded Generics Market: Gastrointestinal Diseases (2013-2018) ($ Millions)
Figure Global Gastrointestinal Diseases YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Branded Generics Consumption Market Share by Application (2013-2018)
Figure Global Branded Generics Consumption Market Share by Application (2013-2018)
Table Global Branded Generics Value by Application (2013-2018)
Table Global Branded Generics Value Market Share by Application (2013-2018)
Figure Global Branded Generics Value Market Share by Application (2013-2018)
Table Global Branded Generics Sale Price by Application (2013-2018)
Table Global Branded Generics Sales by Players (2016-2018) (K MT)
Table Global Branded Generics Sales Market Share by Players (2016-2018)
Figure Global Branded Generics Sales Market Share by Players in 2016
Figure Global Branded Generics Sales Market Share by Players in 2017
Table Global Branded Generics Revenue by Players (2016-2018) ($ Millions)
Table Global Branded Generics Revenue Market Share by Players (2016-2018)
Figure Global Branded Generics Revenue Market Share by Players in 2016
Figure Global Branded Generics Revenue Market Share by Players in 2017
Table Global Branded Generics Sale Price by Players (2016-2018)
Figure Global Branded Generics Sale Price by Players in 2017
Table Global Branded Generics Manufacturing Base Distribution and Sales Area by Players
Table Players Branded Generics Products Offered
Table Branded Generics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Branded Generics Consumption by Regions 2013-2018 (K MT)
Table Global Branded Generics Consumption Market Share by Regions 2013-2018
Figure Global Branded Generics Consumption Market Share by Regions 2013-2018
Table Global Branded Generics Value by Regions 2013-2018 ($ Millions)
Table Global Branded Generics Value Market Share by Regions 2013-2018
Figure Global Branded Generics Value Market Share by Regions 2013-2018
Figure Americas Branded Generics Consumption 2013-2018 (K MT)
Figure Americas Branded Generics Value 2013-2018 ($ Millions)
Figure APAC Branded Generics Consumption 2013-2018 (K MT)
Figure APAC Branded Generics Value 2013-2018 ($ Millions)
Figure Europe Branded Generics Consumption 2013-2018 (K MT)
Figure Europe Branded Generics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Branded Generics Consumption 2013-2018 (K MT)
Figure Middle East & Africa Branded Generics Value 2013-2018 ($ Millions)
Table Americas Branded Generics Consumption by Countries (2013-2018) (K MT)
Table Americas Branded Generics Consumption Market Share by Countries (2013-2018)
Figure Americas Branded Generics Consumption Market Share by Countries in 2017
Table Americas Branded Generics Value by Countries (2013-2018) ($ Millions)
Table Americas Branded Generics Value Market Share by Countries (2013-2018)
Figure Americas Branded Generics Value Market Share by Countries in 2017
Table Americas Branded Generics Consumption by Type (2013-2018) (K MT)
Table Americas Branded Generics Consumption Market Share by Type (2013-2018)
Figure Americas Branded Generics Consumption Market Share by Type in 2017
Table Americas Branded Generics Consumption by Application (2013-2018) (K MT)
Table Americas Branded Generics Consumption Market Share by Application (2013-2018)
Figure Americas Branded Generics Consumption Market Share by Application in 2017
Figure United States Branded Generics Consumption Growth 2013-2018 (K MT)
Figure United States Branded Generics Value Growth 2013-2018 ($ Millions)
Figure Canada Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Canada Branded Generics Value Growth 2013-2018 ($ Millions)
Figure Mexico Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Mexico Branded Generics Value Growth 2013-2018 ($ Millions)
Table APAC Branded Generics Consumption by Countries (2013-2018) (K MT)
Table APAC Branded Generics Consumption Market Share by Countries (2013-2018)
Figure APAC Branded Generics Consumption Market Share by Countries in 2017
Table APAC Branded Generics Value by Countries (2013-2018) ($ Millions)
Table APAC Branded Generics Value Market Share by Countries (2013-2018)
Figure APAC Branded Generics Value Market Share by Countries in 2017
Table APAC Branded Generics Consumption by Type (2013-2018) (K MT)
Table APAC Branded Generics Consumption Market Share by Type (2013-2018)
Figure APAC Branded Generics Consumption Market Share by Type in 2017
Table APAC Branded Generics Consumption by Application (2013-2018) (K MT)
Table APAC Branded Generics Consumption Market Share by Application (2013-2018)
Figure APAC Branded Generics Consumption Market Share by Application in 2017
Figure China Branded Generics Consumption Growth 2013-2018 (K MT)
Figure China Branded Generics Value Growth 2013-2018 ($ Millions)
Figure Japan Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Japan Branded Generics Value Growth 2013-2018 ($ Millions)
Figure Korea Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Korea Branded Generics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Southeast Asia Branded Generics Value Growth 2013-2018 ($ Millions)
Figure India Branded Generics Consumption Growth 2013-2018 (K MT)
Figure India Branded Generics Value Growth 2013-2018 ($ Millions)
Figure Australia Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Australia Branded Generics Value Growth 2013-2018 ($ Millions)
Table Europe Branded Generics Consumption by Countries (2013-2018) (K MT)
Table Europe Branded Generics Consumption Market Share by Countries (2013-2018)
Figure Europe Branded Generics Consumption Market Share by Countries in 2017
Table Europe Branded Generics Value by Countries (2013-2018) ($ Millions)
Table Europe Branded Generics Value Market Share by Countries (2013-2018)
Figure Europe Branded Generics Value Market Share by Countries in 2017
Table Europe Branded Generics Consumption by Type (2013-2018) (K MT)
Table Europe Branded Generics Consumption Market Share by Type (2013-2018)
Figure Europe Branded Generics Consumption Market Share by Type in 2017
Table Europe Branded Generics Consumption by Application (2013-2018) (K MT)
Table Europe Branded Generics Consumption Market Share by Application (2013-2018)
Figure Europe Branded Generics Consumption Market Share by Application in 2017
Figure Germany Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Germany Branded Generics Value Growth 2013-2018 ($ Millions)
Figure France Branded Generics Consumption Growth 2013-2018 (K MT)
Figure France Branded Generics Value Growth 2013-2018 ($ Millions)
Figure UK Branded Generics Consumption Growth 2013-2018 (K MT)
Figure UK Branded Generics Value Growth 2013-2018 ($ Millions)
Figure Italy Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Italy Branded Generics Value Growth 2013-2018 ($ Millions)
Figure Russia Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Russia Branded Generics Value Growth 2013-2018 ($ Millions)
Figure Spain Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Spain Branded Generics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Branded Generics Consumption by Countries (2013-2018) (K MT)
Table Middle East & Africa Branded Generics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Branded Generics Consumption Market Share by Countries in 2017
Table Middle East & Africa Branded Generics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Branded Generics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Branded Generics Value Market Share by Countries in 2017
Table Middle East & Africa Branded Generics Consumption by Type (2013-2018) (K MT)
Table Middle East & Africa Branded Generics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Branded Generics Consumption Market Share by Type in 2017
Table Middle East & Africa Branded Generics Consumption by Application (2013-2018) (K MT)
Table Middle East & Africa Branded Generics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Branded Generics Consumption Market Share by Application in 2017
Figure Egypt Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Egypt Branded Generics Value Growth 2013-2018 ($ Millions)
Figure South Africa Branded Generics Consumption Growth 2013-2018 (K MT)
Figure South Africa Branded Generics Value Growth 2013-2018 ($ Millions)
Figure Israel Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Israel Branded Generics Value Growth 2013-2018 ($ Millions)
Figure Turkey Branded Generics Consumption Growth 2013-2018 (K MT)
Figure Turkey Branded Generics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Branded Generics Consumption Growth 2013-2018 (K MT)
Figure GCC Countries Branded Generics Value Growth 2013-2018 ($ Millions)
Table Branded Generics Distributors List
Table Branded Generics Customer List
Figure Global Branded Generics Consumption Growth Rate Forecast (2018-2023) (K MT)
Figure Global Branded Generics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Branded Generics Consumption Forecast by Countries (2018-2023) (K MT)
Table Global Branded Generics Consumption Market Forecast by Regions
Table Global Branded Generics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Branded Generics Value Market Share Forecast by Regions
Figure Americas Branded Generics Consumption 2018-2023 (K MT)
Figure Americas Branded Generics Value 2018-2023 ($ Millions)
Figure APAC Branded Generics Consumption 2018-2023 (K MT)
Figure APAC Branded Generics Value 2018-2023 ($ Millions)
Figure Europe Branded Generics Consumption 2018-2023 (K MT)
Figure Europe Branded Generics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Branded Generics Consumption 2018-2023 (K MT)
Figure Middle East & Africa Branded Generics Value 2018-2023 ($ Millions)
Figure United States Branded Generics Consumption 2018-2023 (K MT)
Figure United States Branded Generics Value 2018-2023 ($ Millions)
Figure Canada Branded Generics Consumption 2018-2023 (K MT)
Figure Canada Branded Generics Value 2018-2023 ($ Millions)
Figure Mexico Branded Generics Consumption 2018-2023 (K MT)
Figure Mexico Branded Generics Value 2018-2023 ($ Millions)
Figure Brazil Branded Generics Consumption 2018-2023 (K MT)
Figure Brazil Branded Generics Value 2018-2023 ($ Millions)
Figure China Branded Generics Consumption 2018-2023 (K MT)
Figure China Branded Generics Value 2018-2023 ($ Millions)
Figure Japan Branded Generics Consumption 2018-2023 (K MT)
Figure Japan Branded Generics Value 2018-2023 ($ Millions)
Figure Korea Branded Generics Consumption 2018-2023 (K MT)
Figure Korea Branded Generics Value 2018-2023 ($ Millions)
Figure Southeast Asia Branded Generics Consumption 2018-2023 (K MT)
Figure Southeast Asia Branded Generics Value 2018-2023 ($ Millions)
Figure India Branded Generics Consumption 2018-2023 (K MT)
Figure India Branded Generics Value 2018-2023 ($ Millions)
Figure Australia Branded Generics Consumption 2018-2023 (K MT)
Figure Australia Branded Generics Value 2018-2023 ($ Millions)
Figure Germany Branded Generics Consumption 2018-2023 (K MT)
Figure Germany Branded Generics Value 2018-2023 ($ Millions)
Figure France Branded Generics Consumption 2018-2023 (K MT)
Figure France Branded Generics Value 2018-2023 ($ Millions)
Figure UK Branded Generics Consumption 2018-2023 (K MT)
Figure UK Branded Generics Value 2018-2023 ($ Millions)
Figure Italy Branded Generics Consumption 2018-2023 (K MT)
Figure Italy Branded Generics Value 2018-2023 ($ Millions)
Figure Russia Branded Generics Consumption 2018-2023 (K MT)
Figure Russia Branded Generics Value 2018-2023 ($ Millions)
Figure Spain Branded Generics Consumption 2018-2023 (K MT)
Figure Spain Branded Generics Value 2018-2023 ($ Millions)
Figure Egypt Branded Generics Consumption 2018-2023 (K MT)
Figure Egypt Branded Generics Value 2018-2023 ($ Millions)
Figure South Africa Branded Generics Consumption 2018-2023 (K MT)
Figure South Africa Branded Generics Value 2018-2023 ($ Millions)
Figure Israel Branded Generics Consumption 2018-2023 (K MT)
Figure Israel Branded Generics Value 2018-2023 ($ Millions)
Figure Turkey Branded Generics Consumption 2018-2023 (K MT)
Figure Turkey Branded Generics Value 2018-2023 ($ Millions)
Figure GCC Countries Branded Generics Consumption 2018-2023 (K MT)
Figure GCC Countries Branded Generics Value 2018-2023 ($ Millions)
Table Global Branded Generics Consumption Forecast by Type (2018-2023) (K MT)
Table Global Branded Generics Consumption Market Share Forecast by Type (2018-2023)
Table Global Branded Generics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Branded Generics Value Market Share Forecast by Type (2018-2023)
Table Global Branded Generics Consumption Forecast by Application (2018-2023) (K MT)
Table Global Branded Generics Consumption Market Share Forecast by Application (2018-2023)
Table Global Branded Generics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Branded Generics Value Market Share Forecast by Application (2018-2023)
Table Mylan NV Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan NV Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan NV Branded Generics Market Share (2016-2018)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis AG Branded Generics Market Share (2016-2018)
Table Eva Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eva Pharmaceutical Industries Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eva Pharmaceutical Industries Branded Generics Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Branded Generics Market Share (2016-2018)
Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharmaceutical Industries Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sun Pharmaceutical Industries Branded Generics Market Share (2016-2018)
Table Aspen Pharmacare Holding Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aspen Pharmacare Holding Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Aspen Pharmacare Holding Branded Generics Market Share (2016-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Abbott Laboratories Branded Generics Market Share (2016-2018)
Table Valeant Pharmaceuticals International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals International Branded Generics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Valeant Pharmaceuticals International Branded Generics Market Share (2016-2018)


【レポートのキーワード】

後発医薬品、経口、非経口、局所的、腫瘍学、心血管疾患、糖尿病、神経学、胃腸疾患

★調査レポート[後発医薬品の世界市場予測2018-2023] (コード:LPIN8N0866)販売に関する免責事項を必ずご確認ください。
★調査レポート[後発医薬品の世界市場予測2018-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆